PRRT2 and cardiac hypertrophy: The activation of PKC occurs through activation of endothelin- and α1 adrenergic receptors, which leads to downstream effects activating PLC, RhoA and PKC, which finally leads to the transcription of genes, resulting in cardiac hypertrophy [78].